Zimbabwe has rejected a major US healthcare agreement worth $367m (272 million pounds) over five years because of Washington's insistence on confidential biological samples.
This rejection came to light after a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesperson has since clarified that the United States was seeking health data for research and commercial purposes while was not willing to guarantee the benefits from any future medical innovations.
"We must now begin the difficult and regrettable process of ending our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for further talks to find a agreement agreeable to both sides so the country's critical HIV programme can continue.
Broader Context
This development follows a comparable situation in neighbouring Kenya, where a court suspended a similar health funding agreement after concerns were filed about the safety of Kenyans' medical information.
Since resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had managed aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to enhance openness and accountability.
According to statements, 16 nations in Africa have to date signed similar health pacts, representing over $18.3bn in new funding.
Details of the Rejected Deal
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy through US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Put simply, our nation would supply the raw materials for medical research without any certainty that the final treatments would be accessible to our population if a future health crisis arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining structures already established through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to manage potential global health emergencies.
"This framework is intended to guarantee that when a nation provides its data, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to further dialogue with our American counterparts on how future collaboration might be designed in a manner that honours the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but urged that talks need to persist considering a large portion of the country's Aids initiatives relied on international support.
"Where specific concerns exist, including those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," the group said.
The halted deal highlights the complex challenges between accepting vital international aid and protecting local interests in an ever more interconnected world.